BRCA1 participates in DNA decatenation.

Nat Struct Mol Biol

Department of Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Published: July 2005

The tumor suppressor BRCA1 has an important function in the maintenance of genomic stability. Increasing evidence suggests that BRCA1 regulates cell cycle checkpoints and DNA repair after DNA damage. However, little is known about its normal function in the absence of DNA damage. Here we show that BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells. Similar to cells treated with the topoisomerase IIalpha inhibitor ICRF-193, BRCA1-deficient cells show lagging chromosomes, indicating a defect in DNA decatenation and chromosome segregation. More directly, BRCA1 deficiency results in defective DNA decatenation in vitro. Finally, topoisomerase IIalpha is ubiquitinated in a BRCA1-dependent manner, and topoisomerase IIalpha ubiquitination correlates with higher DNA decatenation activity. Together these results suggest an important role of BRCA1 in DNA decatenation and reveal a previously unknown function of BRCA1 in the maintenance of genomic stability.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nsmb953DOI Listing

Publication Analysis

Top Keywords

dna decatenation
20
topoisomerase iialpha
16
dna
8
maintenance genomic
8
genomic stability
8
dna damage
8
brca1
7
decatenation
5
brca1 participates
4
participates dna
4

Similar Publications

Incomplete sister centromere decatenation results in centromeric ultrafine anaphase bridges (UFBs). PICH (PLK1-interacting checkpoint helicase), a DNA translocase, plays a crucial role in UFB resolution by recruiting UFB-binding proteins and stimulating topoisomerase IIα. However, the involvement of distinct PICH functions in UFB resolution remains ambiguous.

View Article and Find Full Text PDF

Untangling bacterial DNA topoisomerases functions.

Biochem Soc Trans

December 2024

Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.

Topoisomerases are the main enzymes capable of resolving the topological constraints imposed by DNA transactions such as transcription or replication. All bacteria possess topoisomerases of different types. Although bacteria with circular replicons should encounter similar DNA topology issues, the distribution of topoisomerases varies from one bacterium to another, suggesting polymorphic functioning.

View Article and Find Full Text PDF
Article Synopsis
  • Argonaute proteins are versatile nucleases present in all life forms, with eukaryotic versions involved in gene regulation and defense against viruses, while their prokaryotic counterparts help bacteria fend off invading genetic material.
  • Recent research indicates that prokaryotic argonautes (pAgos) may protect bacteria from the antibiotic ciprofloxacin, suggesting a potential role in DNA replication and repair.
  • The authors propose models for how pAgos could contribute to ciprofloxacin resistance, including assisting with DNA decatenation, processing DNA repair intermediates, or triggering the SOS response that enhances overall DNA repair and antibiotic resistance.
View Article and Find Full Text PDF

Unveiling the potential of germinated black bean extracts: Targeting topoisomerase IIα through in silico and in vitro approaches.

Food Chem

February 2025

State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi 214122, China. Electronic address:

This study investigates the potential of germinated black bean extracts (GBBE) to modulate the activity of topoisomerase IIα (topo IIα), a key enzyme involved in DNA replication and repair, particularly in triple-negative breast cancer (TNBC). Germination significantly elevated the polyphenolic content of black beans, thereby enhancing their antioxidant properties. Molecular docking studies demonstrated a strong interaction between GBBE and the active site of topo IIα, suggesting a possible mechanism for its inhibitory action.

View Article and Find Full Text PDF
Article Synopsis
  • * Spiropyrimidinetriones (SPTs), like zoliflodacin, have been developed to fight this resistance and show effectiveness against uncomplicated gonorrhea during human trials.
  • * Zoliflodacin is more potent against gyrase than topoisomerase IV, producing more DNA cleavage, and the new SPT H3D-005722 shows promise for achieving balanced targeting of both enzymes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!